Connecticut Bond Commission approves Jackson Laboratory funding

Date: January 31, 2012
| Share

Bar Harbor, Maine—The Connecticut Bond Commission yesterday approved $291 million in state borrowing to construct The Jackson Laboratory for Genomic Medicine in Farmington, Conn.

In October, the Connecticut General Assembly voted in favor of sending the bond proposal to the Commission, with the Governor signing the final agreement for the project on Jan. 5.

JAX Genomic Medicine will unite doctors, patients, scientists and industry to find new ways to tailor disease diagnosis, prevention and treatment to each person’s unique genetic makeup, or genome. Initial operations will begin this year in leased space while a 173,000-square-foot permanent facility is designed and built. Construction will begin in 2013, and the new facility will open in 2014.

The Jackson Laboratory is an independent, nonprofit biomedical research institution and National Cancer Institute-designated Cancer Center based in Bar Harbor, Maine, with a facility in Sacramento, Calif., a future institute in Farmington, Conn., and a total staff of about 1,400. Its mission is to discover the genetic basis for preventing, treating and curing human disease, and to enable research and education for the global biomedical community.


Joyce Peterson, 207-288-6058, The Jackson Laboratory

For information on automatic email delivery of news releases (journalists only), please send an email request for details to Please address other inquiries to

Media Relations, Communications Office
The Jackson Laboratory
600 Main Street
Bar Harbor, Maine 04609-1500
Phone: 207-288-6058 (journalists only)
Main Jackson Laboratory phone: 207-288-6000
Fax: 207-288-6076